
Kevin Cast, Partner, Archbow Consulting
Advertisement
Articles by Kevin Cast, Partner, Archbow Consulting

Advertisement
Latest Updated Articles
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access StrategiesPublished: January 31st 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
3
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5